ASTH (Astrana Health) 6-Month Share Buyback Ratio: 0.89% (As of Mar. 2026 )

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASTH Astrana Health Inc ASTH
87 GF Score
Price $47.04
GF Value $83.12
Valuation Significantly Undervalued
! 8 Warning Signs
View Full Analysis

What is Astrana Health 6-Month Share Buyback Ratio?

Astrana Health ASTH -4.00% 87 6-Month Share Buyback Ratio is 0.89 as of Mar. 2026. GuruFocus rates ASTH with a GF Score™ of 87/100 and a GF Value™ of $83.12 (Significantly Undervalued). The stock has 8 warning signs investors should review.

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

6-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past six months, calculated as the percentage change in shares outstanding from two quarters ago to the current quarter. A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance. Astrana Health's current 6-Month Share Buyback Ratio was 0.89%.

Astrana Health  (NAS:ASTH) 6-Month Share Buyback Ratio Explanation

A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

Astrana Health 6-Month Share Buyback Ratio Related Terms

ASTH vs SGRY, SEM, MD: 6-Month Share Buyback Ratio Comparison

For the Medical Care Facilities subindustry, Astrana Health's 6-Month Share Buyback Ratio, along with its competitors' market caps and 6-Month Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Astrana Health 6-Month Share Buyback Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Astrana Health's 6-Month Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Astrana Health's 6-Month Share Buyback Ratio falls into.


ASTH
87GF Score
Astrana Health Inc ASTH
6-Month Share Buyback Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Astrana Health 6-Month Share Buyback Ratio Calculation

Astrana Health's 6-Month Share Buyback Ratio for the quarter that ended in Mar. 2026 is calculated as

6-Month Share Buyback Ratio=(Shares Outstanding (EOP) (Sep. 2025 ) - Shares Outstanding (EOP) (Mar. 2026 )) / Shares Outstanding (EOP) (Sep. 2025 )
=(49.384 - 48.946) / 49.384
=0.89%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a 6-Month Share Buyback Ratio of 0.89 mean?
Astrana Health (ASTH) has a 6-Month Share Buyback Ratio of 0.89 as of Mar. 2026. The 6-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past six months, calculated as the percentage change in shares outstanding from two quarters ago to the current quarter. View historical data for Astrana Health and its competitors.
Is Astrana Health's 6-Month Share Buyback Ratio too high?
Astrana Health's current 6-Month Share Buyback Ratio is 0.89. Overall, Astrana Health has a GF Score™ of 87/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Astrana Health's 6-Month Share Buyback Ratio compare to SGRY and SEM?
Astrana Health's 6-Month Share Buyback Ratio of 0.89 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 6-Month Share Buyback Ratio for a Healthcare Providers & Services company?
A good 6-Month Share Buyback Ratio depends on the Healthcare Providers & Services industry context. However, 6-Month Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 6-Month Share Buyback Ratio mean?
A high 6-Month Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 6-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past six months, calculated as the percentage change in shares outstanding from two quarters ago to the current quarter. View historical data for Astrana Health and its competitors. Astrana Health's current 6-Month Share Buyback Ratio is 0.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Astrana Health stock overvalued right now?
Based on GuruFocus' analysis, Astrana Health (ASTH) is currently considered Significantly Undervalued. The stock's GF Value™ is $83.12, compared to a current price of $47.04 — trading 43.4% below its estimated fair value. The current 6-Month Share Buyback Ratio is 0.89. Astrana Health's overall GF Score™ is 87/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 6-Month Share Buyback Ratio calculated?
6-Month Share Buyback Ratio is calculated from a company's financial statements. For Astrana Health (ASTH), the current 6-Month Share Buyback Ratio is 0.89 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Astrana Health (ASTH) Overvalued in 2026?

Based on GuruFocus' analysis, Astrana Health stock appears to be undervalued. The current stock price of $47.04 is trading 43.4% below its estimated GF Value™ of $83.12. GuruFocus considers Astrana Health to be Significantly Undervalued.

Key valuation signals for ASTH:

  • 6-Month Share Buyback Ratio: 0.89
  • GF Value™: $83.12 vs. price of $47.04 (43.4% below fair value)
  • GF Score™: 87/100 with 8 warning signs

No single metric tells the full story. See the ASTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Astrana Health Business Description

Other Exchanges 3AM:Germany
Address 1668 South Garfield Avenue, 2nd Floor, Alhambra, CA, USA, 91801
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
87GF Score

Get the complete analysis for ASTH

6-Month Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$47.04
Price
$83.12
GF Value